top of page

Search Results

Results found for "Montana Molecular"

  • 📰 GPCR Weekly News, June 5 to 11, 2023

    GPCR Symposium on Structural and Molecular Insights on GPCR Activation. Berchiche is at the Molecular Pharmacology GRC, if you are also on-site, please stop by and say hi. Structural and Molecular Insights into GPCR Function Structural insights into ligand recognition and

  • 📰 GPCR Weekly News, September 11 to 17, 2023

    Genetic atlas of hygro-and thermosensory cells in the vinegar fly Drosophila melanogaster Structural and Molecular 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10

  • Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal

    Molecules that look promising in vitro often unravel in vivo. Programs stall. Timelines stretch. A well-behaved molecule in a dish can fail spectacularly in vivo, leaving teams with years of sunk costs “The sooner you get your molecule in vivo, the sooner you know whether anything’s happening—and whether Allosteric antibodies can mirror or exceed small molecule complexity. Every molecule tells a story about how it binds, signals, and behaves.

  • Is Your Agonist Really “Working”—Or Are You Just Seeing What Your System Allows?

    Imagine testing a molecule, seeing no response, and shelving it. It’s not just about what your molecule does —it’s also about how capable your system is at showing it

  • Why Opposing Processes Matter for Your Next GPCR Drug

    One wrong assumption about how your molecule behaves in a living system can sink months of work and millions If your job is to move molecules confidently toward the clinic, this is a blueprint for building a more Volunteer Gap Many programs die in Phase II, not because the molecule is “bad,” but because its profile Your molecule isn’t failing—your model might be too simple. you’re serious about derisking your pipeline, this is where you sharpen the tools that actually move molecules

  • 📰 GPCR Weekly News, February 13 to 19, 2023

    Octopamine and tyramine signalling in Aedes aegypti: Molecular characterization and insight into potential Structural and Molecular Insights into GPCR Function Quantitative analysis of sterol-modulated monomer-dimer (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023).

  • 📰 GPCR Weekly News, March 6 to 12, 2023

    Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization Molecular sensing of mechano- and ligand-dependent adhesion GPCR dissociation. (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023).

  • Ben Clements on Rescuing Opioids with GPCR Modulators

    – Ben Clements By combining chronic pain models with receptor-level pharmacology, Ben is bridging molecule With collaborations across medicinal chemistry and neuropathic pain research, Ben is bridging molecule to model and molecule to patient.

  • 📰 GPCR Weekly News

    Structural and Molecular Insights into GPCR Function Global insights into the fine tuning of human A2AAR GPCR drug for interstitial cystitis/bladder pain syndrome: in silico protein structure analysis and molecular Deadline February 12, 2023 Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology June 4-8,2023. 2023 Molecular Pharmacology (GRS) Seminar GRC. June 10 - 11.

  • 📰 GPCR Weekly News, December 11 to 17, 2023

    SARS-CoV-2 Microscopy and spectroscopy approaches to study GPCR structure and function Structural and Molecular - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4,

  • Unlocking the Future of Medicine: Advancements in GPCR Research

    Principles of Pharmacology in Drug Discovery I - Techniques for Effective Lead Optimization of Candidate Molecules Structural and Molecular Insights into GPCR Function Entropy drives the ligand recognition in G-protein-coupled

  • 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024

    mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Photo-BQCA: Positive Allosteric Modulators Enabling Optical Control of the M1 Receptor The cell adhesion molecule

  • Do You Believe AI Could Accelerate Drug Discovery?

    protein structures is transformative for identifying new drug targets and designing effective drug molecules Lyu et al. prospectively docked ultra-large libraries of molecules against unrefined AF2 models of the Docking 490 million molecules against the σ2 receptor's AF2 model yielded a 54% hit rate, comparable Of 161 molecules tested, 42 substituted more than 50% of [³H]-LSD at 10 μM, achieving a 26% hit rate. Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions

  • A cryptic mode of GPCR regulation revealed

    In a recent issue of Molecular Cell, Fonseca et al. identified a previously overlooked desensitization

  • 📰 GPCR Weekly News, May 6 to 12, 2024

    in GPCR Research ONE-GO: Direct detection of context-dependent GPCR activity Author Correction: GPCR molecular cooperative GPCR:G protein interactions that contribute to G protein coupling Reviews, GPCRs, and more Molecular comprehensive GPCR-transducer-deficient cell lines to dissect complexity of GPCR signaling Structural and Molecular

  • Feeder or trigger – CCR2 as a scavenger and regulator of cell migration

    Molecular signature of CCR2 scavenging - no G proteins, no GRKs, no arrestins, and no clathrin Chemokine and recycling of the receptor with clearance of the ligand from the extracellular space however, the molecular In this study, the molecular signature of CCR2 scavenging role is investigated. In this study, the role of these 3 molecular players (G proteins, GRKs, and β-arrestin) is investigated

  • Function and structure of bradykinin receptor 2 for drug discovery

    The recently determined structures of B2R have provided molecular insights into the functions and regulation

  • Diversification of PAR signaling through receptor crosstalk

    the physiological and pathological relevance of these interactions, since this additional level of molecular

  • 📰 GPCR Weekly News, April 17 to 23, 2023

    Structural and Molecular Insights into GPCR Function Lysophosphatidic acid, a simple phospholipid with (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023).

  • Endocannabinoid System in the Neuroendocrine Response to Lipopolysaccharide-induced Immune Challenge

    Here we explore which actors and molecular mechanisms are involved in these processes."

  • Overview of adhesion GPCRs self-activation

    Last month a very detailed paper analyzed the molecular mechanisms of the aGPCRs self-activation as well This paper proposes a series of molecular mechanisms that would be occurring during the self-activation In view of the above, these new findings clearly demonstrate part of the molecular mechanisms involved Molecular cell, 82(22), 4340–4352.e6.

  • GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma

    Through genetic and pharmacologic modulations of GRK3, a series of functional and molecular studies were

  • Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype

    their properties and exhibit the current state-of-the-art pallet of promising drug candidates or useful molecular

  • GPCRS: AN ODYSSEY FROM STRUCTURE, SIGNALING AND REGULATION TO THERAPEUTICS

    SNOWBIRD RESORT, UTAH, UNITED STATES The superfamily of G protein-coupled receptors (GPCRs) act as molecular While GPCRs are considered a well-established field, recent technological advances to dissect the molecular

  • Dr. Nicola J. Smith - Dr. GPCR Podcast

    Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney.

  • Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

    CB2 ligand development and progress in optimising physicochemical properties, understanding advanced molecular

  • Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future

    CB2 ligand development and progress in optimizing physicochemical properties, understanding advanced molecular

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4,

  • From DNA day to GPCR genomics

    The discovery of DNA's double helical structure was a scientific milestone that revolutionized molecular Molecular pharmacology, 63(6), 1256–1272. https://doi.org/10.1124/mol.63.6.1256 Syed Haneef, S.

  • 📰 GPCR Weekly News, March 27 to April 4, 2023

    Structural and Molecular Insights into GPCR Function Predicted Three-Dimensional Structure of the GCR1 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based de novo molecular (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023).

bottom of page